Tag: environment

EINDHOVEN, The Netherlands, June 12, 2025 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI), the worldwide leader in automotive processing, today announced its collaboration with Rimac Technology, a leading automotive industry supplier specialized in high-performance control systems, to advance centralized architectures for SDVs. The jointly developed solution features NXP’s S32E2 processors, which are part of NXP's comprehensive S32 Automotive Processing Platform, designed for current and future connectivity, security and safety challenges in automotive. The S32E addresses the vehicle’s need for high-performance deterministic real-time domain and zonal control in a multi-applications environment.

BRUSSELS and CAMBRIDGE, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ: BIIB) today presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate. In the study, DZP demonstrated significant clinical improvements in disease activity in people living with moderate-to-severe systemic lupus erythematosus (SLE), as measured by the British Isles Lupus Assessment Group (BILAG)-based Composite Lupus Assessment (BICLA) at Week 48, the primary endpoint. Improvements were also seen across additional clinical measures, including fatigue and disease activity/remission. These results were presented at EULAR 2025, the European Alliance of Associations for Rheumatology’s annual meeting, in Barcelona, Spain. The safety and efficacy of DZP in SLE have not been established, and it is not approved for use in SLE by any regulatory authority worldwide. A second Phase 3 trial of dapirolizumab pegol is ongoing with the goal of confirming the results from PHOENYCS GO.

Bethesda-based advisory firm introduces a new framework for risk mitigation, tax efficiency, and strategic capital access tailored to visionary business owners.